nach oben

Reactions Weekly

Erschienen in:

01.05.2010 | Case report

Dasatinib

First report of acute lymphoblastic leukaemia: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2010

Einloggen, um Zugang zu erhalten

Excerpt

An event is serious (FDA MedWatch definition) when the patient outcome is:

death
life-threatening
hospitalisation
disability
congenital anomaly
requires intervention to prevent permanent impairment or damage

…

Santos FPS, Rodrigues M, Mac-Donald Bley Do Nascimento C, Kerbauy FR, Ribeiro AAF, Mauro Kutner J, Hamerschlak N.Philadelphia-negative acute lymphoblastic leukemia in a chronic myeloid leukemia patient receiving dasatinib. Cytotherapy 12: 113-115, No. 1, Jan 2010. Available from: URL: http://dx.doi.org/10.3109/14653240903300666 - Brazil

Titel: Dasatinib
First report of acute lymphoblastic leukaemia: case report
Publikationsdatum: 01.05.2010
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2010
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.2165/00128415-201013000-00053

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Dasatinib

First report of acute lymphoblastic leukaemia: case report

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2010

HIV/HCV coinfection ups risk of liver toxicity during HAART

Venlafaxine

Sunitinib

Long-term lacosamide treatment is generally well tolerated, with AE* incidences similar to those reported in short-term trials,

Pfizer discontinued their phase III trial of sunitinib [Sutent] in advanced liver cancer,

Ciprofloxacin